To determine the impact of combined TME Stimulation (estrogen+TNFα+EGF) on tumor cell heterogeneity, two very well-established human Luminal-A breast tumor cell lines were used in our current study, MCF-7 and T47D cells. This evidence concerns the gene EGF and breast neoplasm.